Comparing two videolaryngoscopes for placing breathing tubes in infants

Comparison of the Effectiveness and Cost-Effectiveness of McGRATH™ MAC and Besdata Videolaryngoscopes in the Orotracheal Intubation of Children: A Non-Inferiority Randomized Clinical Trial

Not applicable Interventional University of Sao Paulo General Hospital · NCT07351227

This trial will test whether the BESDATA BD-DF videolaryngoscope works as well as the McGRATH MAC for placing breathing tubes on the first try in infants aged 6 months to 3 years during elective surgery.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment226 (estimated)
Ages6 Months to 3 Years
SexAll
SponsorUniversity of Sao Paulo General Hospital Academic / other
Locations1 site (São Paulo, São Paulo)
Trial IDNCT07351227 on ClinicalTrials.gov

What this trial studies

This is a randomized, single-center trial at the Hospital das Clínicas (University of São Paulo) that assigns infants to intubation with either the BESDATA BD-DF or the McGRATH MAC videolaryngoscope. The primary outcome is successful orotracheal intubation on the first attempt, with secondary measures including procedure time, number of attempts, airway-related complications, and device-related costs. Infants eligible are between 6 months and 3 years undergoing elective general anesthesia, with exclusions for significant airway anomalies, hemodynamic instability, or ASA IV and above. The study combines clinical performance data with an economic comparison to inform device selection in pediatric airway management.

Who should consider this trial

Good fit: Ideal candidates are infants aged 6 months to 3 years scheduled for elective surgery under general anesthesia at the Children's Institute (Instituto da Criança) of HC-FMUSP whose parents or legal guardians provide informed consent.

Not a fit: Infants with craniofacial abnormalities or oral deformities suggesting a difficult airway, those who are hemodynamically unstable, classified ASA IV or higher, or outside the 6 months–3 years age range are excluded and unlikely to benefit from this comparison.

Why it matters

Potential benefit: If successful, the trial could identify a device that increases first-attempt intubation success and reduces complications and costs for infants needing airway management during surgery.

How similar studies have performed: The McGRATH MAC has been more extensively studied and commonly used in pediatrics with supportive data on visualization and success, but head-to-head comparisons with the newer BESDATA device in infants are currently lacking.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will include children aged between 6 months and 3 years who are scheduled for elective surgery under general anesthesia at the Children's Institute (Instituto da Criança - ICr) of the Hospital das Clínicas Complex, University of São Paulo Medical School (HC-FMUSP), provided that informed consent is obtained from their parents or legal guardians.

Exclusion Criteria:

* Patients under one year of age will be excluded if informed consent is not obtained from their legal guardians, if they are classified as ASA physical status IV or higher, present with hemodynamic instability, or have craniofacial abnormalities or oral deformities suggestive of a potentially difficult airway.

Where this trial is running

São Paulo, São Paulo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Intubation, IntratrachealAirway ManagementVideo LaryngoscopeCost EffectivenessVideolaryngoscopePediatric orotracheal intubationCost effectivenessMcGrath MAC
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.